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of Coronary Artery Calciﬁcation
Ammar Sarwar, MD,* Leslee J. Shaw, PHD,† Michael D. Shapiro, DO,*
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Suhny Abbara, MD,* Thomas J. Brady, MD,* Matthew J. Budoff, MD,‡
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O B J E C T I V E S In this study, we systematically assessed the diagnostic and prognostic value of absence
of coronary artery calciﬁcation (CAC) in asymptomatic and symptomatic individuals.
B A C KG ROUND Presence of CAC is a well-established marker of coronary plaque burden and is
associated with a higher risk of adverse cardiovascular outcomes. Absence of CAC has been suggested to be
associated with a very low risk of signiﬁcant coronary artery disease, as well as minimal risk of future events.
METHOD S We searched online databases (e.g., PubMed and MEDLINE) for original research articles
published in English between January 1990 and March 2008 examining the diagnostic and prognostic utility
of CAC.
R E S U L T S A systematic review of published articles revealed 49 studies that fulﬁlled our criteria for
inclusion. These included 13 studies assessing the relationship of CAC with adverse cardiovascular outcomes
in 64,873 asymptomatic patients. In this cohort, 146 of 25,903 patients without CAC (0.56%) had a
cardiovascular event during a mean follow-up period of 51 months. In the 7 studies assessing the prognostic
value of CAC in a symptomatic population, 1.80% of patients without CAC had a cardiovascular event. Overall,
18 studies demonstrated that the presence of any CAC had a pooled sensitivity and negative predictive value
of 98% and 93%, respectively, for detection of signiﬁcant coronary artery disease on invasive coronary
angiography. In 4,870 individuals undergoing myocardial perfusion and CAC testing, in the absence of CAC,
only 6% demonstrated any sign of ischemia. Finally, 3 studies demonstrated that absence of CAC had a
negative predictive value of 99% for ruling out acute coronary syndrome.
CONC L U S I O N S On the basis of our review of more than 85,000 patients, we conclude that the
absence of CAC is associated with a very low risk of future cardiovascular events, with modest incremental
value of other diagnostic tests in this very low-risk group. (J Am Coll Cardiol Img 2009;2:675–88) © 2009 by
the American College of Cardiology Foundation
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676he evaluation of coronary artery calcium
(CAC) has undergone dramatic evolution
over the past few decades. Published studies
range from initial descriptions in histology
tudies (1,2) to cross-sectional and longitudinal
tudies using cine fluoroscopy (3,4), electron beam
omputed tomography (5), and multidetector com-
uted tomography (6). There have been recommen-
ations for examining the presence of CAC in the
ontext of mass scores (7) and volume scores (8), as
ell as scores based on area of calcified plaque and
ttenuation (Agatston score) (9). The quantification
f CAC has been further complicated by studies
hat recommend different categories of CAC ex-
ent, such as quartiles (10) or age- and sex-specific
ercentiles (11), for optimal risk stratification.
See page 689
Therefore, the purpose of this review
was to provide a “back to the basics”
approach examining the clinical, diagnos-
tic, and prognostic significance of the ab-
sence of CAC. We examined published
reports for the relevance of the absence of
CAC in the context of 3 major categories:
1) its prognostic utility in categorizing
both asymptomatic and symptomatic pa-
tients according to their risk for adverse
events; 2) its relationship with the pres-
ence or absence of significant coronary
artery stenosis by invasive coronary an-
giography; and 3) the degree of myocardial
ischemia detected in those with the ab-
sence of CAC.
E T H O D S
e searched the MEDLINE database for studies
ublished in the English language between January
990 and March 2008, assessing CAC using either
ultidetector computed tomography or electron
eam computed tomography in adult populations of
oth sexes. The search was performed using various
ermutations of the following search terms: “elec-
ron beam computed tomography,” “multidetector
omputed tomography,” “coronary artery calcium,”
coronary artery calcification,” “invasive coronary
ngiography,” and “myocardial perfusion imaging.”
dditional references were found by reviewing bib-
iographies from identified articles. Individual arti-
les had to meet the following criteria to be in-
m
se
inluded: 1) articles examining the relationship petween CAC and adverse cardiovascular events in
symptomatic individuals; only studies that pro-
pectively enrolled asymptomatic patients and had a
ollow-up 1 year for cardiovascular events were
ncluded. Authors of articles that did not contain
ata on patients without CAC were contacted for
ore information. 2) Articles examining the rela-
ionship between CAC and adverse cardiovascular
vents in symptomatic individuals. 3) Articles exam-
ning the relationship between CAC and invasive
oronary angiography (ICA) and defining a significant
tenosis as 50% coronary luminal narrowing. 4)
rticles comparing the incidence of myocardial per-
usion abnormalities with the extent of CAC. 5)
rticles reporting the ability of CAC to predict acute
oronary syndromes. We contacted authors of studies
n which the incidence of coronary artery disease
CAD) in patients without CAC was not reported or
ould not be calculated.
tatistical analysis. Based on the 2  2 event data
or patients with no CAC and CAC 0, individual
nd summary Mantel-Haenszel relative risk ratios
nd 95% confidence intervals (CIs) were calculated
Comprehensive Meta-Analysis, version 2.2, Bio-
tat, Englewood, New Jersey). For this analysis, a
umulative relative risk ratio was displayed in a
orest plot. Although duplicate series were in-
luded in the plot, the summary risk ratio was
alculated using only the latter series. For reports
howing no events in patients with 0 CAC, 1 event
as added so that the relative risk ratio could be
alculated. The test for heterogeneity for asymp-
omatic patients was significant (Q statistic  26, p
0.001); however, inclusion of studies published
fter 2004 revealed greater homogeneity in study
esults (Q statistic  6, p  0.19). Presentation of
he data with and without publications before 2004,
owever, did not change the results noted herein. A
unnel plot was created to estimate publication bias
nd is included in the online version of this article.
or asymptomatic individuals, a review of this plot
eveals that 4 series with results outside the preci-
ion lines may suggest publication bias, including
reenland (17), Shemesh (16), Raggi (11), and
ong (13), all with sample sizes 1,030. For
symptomatic individuals, the classic fail-safe num-
er of missing studies that would bring the p value
oalpha 0.05 was 1,354; if the alpha is changed
o 0.01, the number of studies missing that would
ring the p value alpha was 779. The test for
eterogeneity in symptomatic patients was nonsig-
ificant (Q statistic  4, p  0.50), suggesting thatB B R E V I A T I O N S
N D A C R O N YM S
CC American College of
ardiology
CS acute coronary
yndromes
HA American Heart
ssociation
AC coronary artery calciu
AD coronary artery disea
I confidence interval
T computed tomography
CA invasive coronary
ngiography
DL low-density lipoprote
PSmyocardial perfusionooling of these reports was appropriate. A funnel
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677lot was also created for symptomatic patient re-
orts. Noted in this plot, there was 1 study exhib-
ting an extreme measure, possibly reflecting publi-
ation bias (5). For the symptomatic series, the
lassic fail-safe number of missing studies that would
ring the p value to alpha  0.01 was only 26.
The positive and negative predictive value and
5% CI for significant CAD were calculated for
ach study and for a summary weighted (propor-
ional to the sample size) measure.
Individual and summary odds ratios and 95% CIs
ere calculated for the frequency of ischemia in
atients with no CAC and CAC 0. For patients
ith no ischemia in the zero-CAC group, a single
ase was added to allow for calculation of the odds
atio. The test for heterogeneity was significant (Q
tatistic  54, p  0.0001), with exclusion of the
e and Rozanski series suggesting more homoge-
eous results (Q statistic  5, p  0.18).
E S U L T S
rognosis in asymptomatic adults. Table 1 compares
3 studies assessing the relationship of CAC with
dverse cardiovascular outcomes consisting of
1,595 asymptomatic patients (65% men) (11–23).
n this cohort, 29,312 patients (41%) did not have
ny evidence of CAC (range 22% to 80% of total
atients per study). These patients were followed
or 32 to 102 months (mean 50 months) for the
ccurrence of cardiovascular events. Overall, 154 of
9,312 patients (0.47%) without CAC had a car-
iovascular event during follow-up, as compared
ith 1,749 of 42,283 patients (4.14%) with CAC.
he cumulative relative risk ratio was 0.15 (95% CI:
.11 to 0.21, p  0.001) (Fig. 1).
rognosis in symptomatic adults. There are 7 studies
ssessing the prognostic value of CAC in the
ymptomatic population (Table 2) (5,24–29). Over-
ll, these studies included a total of 3,924 symp-
omatic patients (60% men), of whom 921 patients
23%) did not have any evidence of CAC. These
atients were followed up for 30 to 84 months
mean 42 months). Overall, 17 of 921 patients
1.8%) without CAC had a cardiovascular event
uring follow-up compared with 270 of 3,003
atients (8.99%) with CAC. The cumulative rela-
ive risk ratio was 0.09 (95% CI: 0.04 to 0.20, p 
.0001) (Fig. 2).
iagnostic accuracy of CAC for stenosis on invasive
ngiography. Quantification of CAC has also been
xtensively studied (30–47) for its ability to predict
ignificant CAD as determined by ICA (Table 3). there were 18 studies from 1992 to 2007 in which
total of 10,355 symptomatic patients suspected of
AD underwent CAC testing, as well as ICA.
verall, 5,805 of these patients (56%) had a signif-
cant coronary stenosis (defined as 50%) on ICA.
n this cohort, 1,941 patients (20%) had no CAC
range 12% to 36% of total patients per study).
verall, only 131 of 5,805 patients (2%) with
ignificant CAD did not have detectable CAC.
ooled data revealed that the presence of calcium
ad a sensitivity, specificity, negative predictive
alue, and positive predictive value of 98%, 40%,
3% and 68%, respectively, for the prediction of a
ignificant coronary stenosis. The summary nega-
ive predictive value was 92% (95% CI: 88% to 95%,
 0.0001) (Fig. 3). The summary positive pre-
ictive value was 68% (95% CI: 64% to 72%, p 
.0001) (Fig. 3).
iagnostic accuracy of CAC for myocardial ischemia.
ight studies (29,48–54) evaluated CAC in pa-
ients undergoing stress myocardial perfusion im-
ging (Table 4). A total of 535 of 3,717 patients
14%) were found to have abnormal myocardial
erfusion. In patients without CAC, 67 of 973 (7%)
ad evidence of ischemia, whereas in patients with
AC (n 2,744), 486 patients (13%) had evidence
f ischemia. The cumulative odds ratio for ischemia
as 0.086 (95% CI: 0.024 to 0.311, p  0.0001)
Fig. 4).
AC in detection of acute coronary syndromes in the
mergency department. Three studies outlined the
tility of CAC scanning for risk stratification of
atients with suspicion of acute coronary syndromes
ACS) (Table 5) (24,55,56). These studies evalu-
ted 431 patients complaining of acute chest pain
ith negative troponins and equivocal electrocar-
iographic findings. The cohort consisted of 48%
en (mean age 51.4 years). There were only 2 of
83 patients (1.1%) without any CAC who were
iagnosed with an ACS. Of the 248 patients with a
ositive CAC score, 77 (31%) were found to have
n ACS. Overall, a positive CAC score had 99%
ensitivity, 57% specificity, 24% positive predictive
alue, and 99% negative predictive value for the
valuation of ACS. The Mantel-Haenszel relative
isk ratio for ACS was 0.07 (95% CI: 0.026 to
.187, p  0.00001) with absence of CAC.
I S C U S S I O N
verall, our review of the published data revealed
hat the absence of CAC translates into a low risk
Table 1. Studies Examining the Prognosis of Asymptomatic Patients on the Basis of Their Coronary Artery Calcium Scores
Author/Year (Ref. #)
Total
Population
Type of
Population
Scanner Type/
Slice Thickness
Men
(%)
Prevalence, n (%) Mean
Follow-up
(Months)
% Age
Lost to
Follow-Up Deﬁnition of Events
Events, n (%)
CAC  0 CAC >0 CAC  0 CAC >0
Arad et al./2000 (12) 1,173 Self referred EBCT/3 mm 71 623 (53) 550 (47) 43 0.4 Cardiac death (3),
myocardial infarction (15),
revascularization (21)
2 (0.32) 37 (6.72)
Raggi et al./2001 (11) 676 PCP referred EBCT/3 mm 50 319 (47) 357 (53) 32 N/A Cardiac death (9),
myocardial infarction (21)
1 (0.31) 29 (4.77)
Wong et al./2002 (13) 926 Self referred EBCT/3 mm 79 398 (43) 528 (57) 40 N/A Myocardial infarction (6),
revascularization (20),
stroke (2)
4 (1.01) 24 (6.12)
Kondos et al./2003 (14) 5,635 Self referred EBCT/3 mm 74 1,816 (32) 3,819 (78) 37 36 Cardiac death (21),
myocardial infarction (37),
revascularization (166)
11 (0.61) 213 (5.58)
Shaw et al./2003 (15) 10,377 PCP referred EBCT/3 mm 60 5,067 (49) 5,310 (51) 60 0 All-cause death (249) 39 (0.77) 210 (3.95)
Shemesh et al./2004 (16) 446 High-risk
hypertensives
MDCT/N/A 48 152 (34) 294 (66) 45 0 Cardiac death (2),
myocardial infarction (16),
revascularization (14),
stroke (15)
6 (3.95) 41 (13.95)
Greenland et al./2004 (17) 1,029 Self referred EBCT/6 mm 90 316 (31) 713 (69) 102 12.5 Cardiac death (68),
myocardial infarction (16)
14 (4.43) 70 (9.82)
Arad et al./2005 (18) 4,903 Population-based
cohort
EBCT/3 mm 65 1,504 (31) 3,399 (69) 52 6 Cardiac death (40),
revascularization (59),
peripheral disease (13),
stroke (7)
8 (0.53) 119 (3.50)
LaMonte et al./2005 (19) 10,746 Self and PCP
referred
EBCT/3 mm 64 2,692 (25) 8,054 (75) 42 30 Cardiac death (19),
myocardial infarction (62),
revascularization (206)
15 (0.56) 272 (3.38)
Taylor et al./2005 (20) 1,983 Army population EBCT/3 mm 82 1,591 (80) 392 (10) 36 0.8 Cardiac death, myocardial
infarction, unstable angina
2 (0.13) 7 (1.79)
Budoff et al./2007 (21) 25,253 PCP referred EBCT/3 mm 54 11,046 (44) 14,207 (56) 82 0 All-cause death (511) 44 (0.40) 466 (3.28)
Becker et al./2008 (22) 1,726 PCP referred EBCT/3 mm 59 379 (22) 1,347 (78) 40 0 Cardiac death (66),
myocardial infarction (114)
0 (0.00) 180 (13.36)
Detrano et al./2008 (23) 6,722 Population-based
cohort (MESA)
EBCT/3 mm 47 3,409 (51) 3,313 (49) 44 0.5 Cardiac death (17),
myocardial infarction (72)
8 (0.23) 81 (2.45)
Pooled 71,595 65 29,312 (41) 42,283 (59) 50 154 (0.47) 1,749 (4.14)
CAC  coronary artery calcium; EBCT  electron beam computed tomography; MDCT  multidetector computed tomography; MESA  Multi-Ethnic Study of Atherosclerosis; PCP  primary care physician.
J
A
C
C
:
C
A
R
D
IO
V
A
S
C
U
L
A
R
IM
A
G
IN
G
,
V
O
L
.
2
,
N
O
.
6
,
2
0
0
9
J
U
N
E
2
0
0
9
:6
7
5
–
8
8
Sarw
aretal.
Pro
g
n
o
stic
V
alu
e
o
fN
o
C
A
C
678
f
t
s
m
c
C
v
p
a
P
A
n
o
d
4
e
r
t
W
t
a
e
s
l
a
e
s
T
a
t
t
(
w
t
s
n
w
p
o
i
e
(
t
y
a
f
w
s
a
T
c
t
s
(
w
p
r
d
isk
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 2 , N O . 6 , 2 0 0 9
J U N E 2 0 0 9 : 6 7 5 – 8 8
Sarwar et al.
Prognostic Value of No CAC
679or future events in both asymptomatic and symp-
omatic populations, a low probability of having a
ignificant stenosis, a low incidence of abnormal
yocardial perfusion, and a low likelihood of acute
oronary syndrome. In summary, the absence of
AC identifies individuals at low risk for cardio-
ascular disease and cardiovascular events, thus
recluding the need for further downstream testing
nd management.
rognostic signiﬁcance. ASYMPTOMATIC PATIENTS.
total of 13 studies examining the prognostic sig-
ificance of CAC in asymptomatic individuals fit
ur criteria for inclusion. There were adverse car-
iac events in an average of 0.47% (range 0 to
.43%) of the total 29,312 individuals without
vidence of CAC. Although 11 studies had event
ates 1.01%, there were 2 studies that had ex-
remely high event rates (3.95 and 4.43%) (16,17).
hen we examined these studies more carefully,
he study with the highest event rates (4.43%) (17)
pplied an unconventional scanning protocol that
mployed a 6-mm slice thickness rather than the
tandard 3-mm collimation. It has been well estab-
ished (57) that use of a larger slice thickness misses
pproximately one-third of calcified lesions. The
ffect of missing these lesions can result in misclas-
ifying individuals as having no evidence of CAC.
he other study with a higher event rate (3.95%)
ssessed 446 high-risk hypertensive patients from
he INSIGHT (International Nifedipine Study In-
Figure 1. Forest Plot of the Cumulative Relative Risk Ratio for E
The relative risk ratio is calculated using a Mantel-Haenszel relative
risks are reported, but the Forest plot details a cumulative relative rervention as Goal for Hypertension Therapy) trial s16). Nearly one-third of the events in this study
ere strokes. Hemorrhagic strokes related to hyper-
ension might have elevated the number of events
een in individuals without CAC. Neither the
ature of the strokes nor the number of patients
ith/without CAC who suffered a stroke was re-
orted in the article.
Overall, despite the results of these 3 studies,
ur review indicates that the absence of CAC
s associated with a very low overall risk of any
vent in asymptomatic individuals. Budoff et al.
21) demonstrated a similarly low risk for mor-
ality (0.4%) in a follow-up extending up to 12
ears, confirming the minimal long-term risk
ssociated with absence of CAC in long-term
ollow-up.
Another key question is how CAC compares
ith other noninvasive tests for subclinical athero-
clerosis such as carotid intimal medial thickness,
nkle-arm pressure index, and C-reactive protein.
his question was examined recently (58) in a
omparative review of subclinical atherosclerosis
ests. The authors found that negative testing for
ubclinical atherosclerosis conveyed a low risk
10%) regardless of the test considered. However,
ith respect to prognostic value in asymptomatic
atients, the data on CAC seem to be the most
obust in sheer size, diversity of populations, and
uration of follow-up. Although other tests for
ts in No CAC Versus CAC Asymptomatic Patients
ratio (95% conﬁdence interval [CI]). The individual study relative
ratio. All p  0.0001. CAC  coronary artery calcium.ven
riskubclinical atherosclerosis have the benefit of low
Table 2. Studies Examining the Prognosis of Patients Symptomatic for Coronary Artery Disease on the Basis of Their Coronary Artery Calcium Scores
Author/Year (Ref. #)
Total
Population Type of Population
Scanner Type/
Slice Thickness
Men
(%)
Prevalence, n (%) Mean
Follow-up
(Months)
% Age
Lost to
Follow-Up Deﬁnition of Events
Events, n (%)
CAC  0 CAC >0 CAC  0 CAC >0
Detrano et al./1996 (5) 491 Referred for ICA EBCT/3 mm 57 98 (20) 393 (80) 30 14 Cardiac death (13),
myocardial infarction (8)
1 (1.02) 20 (5.09)
Georgiou et al./2001 (24) 192 Referred to
emergency
department for
chest pain
EBCT/3 mm 54 76 (40) 116 (60) 50 8 Cardiac death (11),
myocardial infarction (19),
revascularization (13),
hospitalizations (11),
strokes (4)
2 (2.63) 56 (48.28)
Keelan et al./2001 (25) 288 Retrospective study,
patients with EBCT
and ICA
EBCT/3 mm 77 32 (11) 256 (89) 84 9 Cardiac death (N/A),
myocardial infarction (N/A)
1 (3.13) 21 (8.20)
Schmermund et al./2004 (26) 255 Retrospective study,
pts with recent
onset of symptoms
EBCT/3 mm 71 62 (24) 193 (76) 42 15 Cardiac death (3),
myocardial infarction (2),
revascularization (35)
1 (1.60) 39 (20.21)
Becker et al./2005 (27) 924 Post ICA, no
signiﬁcant stenosis
MDCT 48 188 (20) 736 (80) 36 N/A Cardiac death (28),
myocardial infarction (50)
0 (0.00) 78 (11)
Rozanski et al./2007 (28) 1,153 PCP/self referred EBCT/ MDCT
3/2.5 mm
74 252 (22) 901 (78) 32 3 Cardiac death and myocardial
infarction (13),
revascularizations
60 days (37)
1 (0.40) 49 (5.44)
Schenker et al./2008 (29) 621 Referred for stress PET
on clinical grounds
MDCT/2.5 mm 40 213 (34) 408 (66) 17 0 Cardiac death (33),
myocardial infarction (22)
11 (5.16) 44 (10.78)
Total 3,924 60 921 (23) 3,003 (76) 42 17 (1.80) 270 (8.99)
ACS  acute coronary syndromes; ICA  invasive coronary angiography; N/A  not applicable; PET  positron emission tomography; other abbreviations as in Table 1.
J
A
C
C
:
C
A
R
D
IO
V
A
S
C
U
L
A
R
IM
A
G
IN
G
,
V
O
L
.
2
,
N
O
.
6
,
2
0
0
9
J
U
N
E
2
0
0
9
:6
7
5
–
8
8
Sarw
aretal.
Pro
g
n
o
stic
V
alu
e
o
fN
o
C
A
C
680
c
p
s
t
w
l
s
s
t
O
y
m
w
o
T
C
r
h
a
a
A
c
r
C
o
i
C
s
r
A
w
o
s
c
f
t
t
i
C
m
q
P
w
l
l
d
c
f
p
f
s
w
m
f
p
o
S
h
i
l
p
C
a
p
e
A
t
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 2 , N O . 6 , 2 0 0 9
J U N E 2 0 0 9 : 6 7 5 – 8 8
Sarwar et al.
Prognostic Value of No CAC
681ost, higher reproducibility, and a better safety
rofile owing to the absence of radiation, none have
hown any added benefit in prognostic value over
raditional risk factors.
Despite its utility, it is important to assess
hether the result of a negative CAC score would
ead asymptomatic individuals to engage in less
tringent adherence to preventive and therapeutic
trategies. The results of a randomized controlled
rial looking at this question suggest otherwise.
’Malley et al. (59) followed 459 young men for 1
ear and found no difference in projected risk, and,
ore importantly, no change in behavior in those
ho were informed that they did not have evidence
f CAC versus those who were found to have CAC.
hey concluded that the knowledge of a negative
AC score scan did not convey false reassurance
esulting in adverse behavioral outcomes.
Another issue that must be closely examined is
ow often individuals without CAC should be
ssessed for development of atherosclerosis and who
mong these individuals may need early follow-up.
study examining progression rates of coronary
alcification in 710 patients without CAC (60)
eported that 62% of the cohort did not develop
AC in a period extending up to 5 years. In fact,
nly 2% developed a CAC score 50 (60). The
nvestigators concluded that after an initial negative
AC scan, an individual can safely receive a follow-up
can up to 5 years later. Similarly, Kronmal et al. (61)
eported from the MESA (Multiethnic Study on
therosclerosis) study that only 16% of individuals
ithout CAC developed CAC in a median follow-up
f 41 months. This indicates that a negative CAC
can could save a patient from costly therapy over the
Figure 2. Forest Plot of the Cumulative Relative Risk Ratio for E
The relative risk ratio is calculated using a Mantel-Haenszel relative
calcium.ourse of 3 to 5 years and that these patients can be tollowed simply with regular outpatient visits without
he need for costly diagnostic imaging.
Although current guidelines do not recommend
hat preventive therapies such as lipid-lowering med-
cations can be down-regulated in the absence of
AC (62), our data suggest that aggressive manage-
ent in this cohort is not warranted if patients do not
ualify according to National Cholesterol Education
rogram guidelines. For example, among individuals
ho are considered as intermediate Framingham risk,
ipid-lowering medications are recommended only for
ow-density lipoprotein (LDL) cholesterol160 mg/
l. In these scenarios, patients with LDL160 mg/dl
an be reassured of their risk without initiation of
urther pharmacotherapy. The results of our review
rovide an opportunity to introduce a robust model
or providing treatment to deserving individuals in
ocieties with finite resources. This would allow those
ith the absence of CAC to follow healthy lifestyle
odifications with little or no medical therapy while
ocusing intense therapy on a smaller population of
atients with an actual higher risk of events as dem-
nstrated by increasing atherosclerotic burden.
YMPTOMATIC PATIENTS. Along with the compre-
ensive literature on the prognostic utility of CAC
n asymptomatic patients, a number of studies
ooked at similar parameters in a symptomatic
opulation (Table 2). Although the prevalence of a
AC score of 0 was lower in symptomatic versus
symptomatic patients (23% vs. 40%), symptomatic
atients without CAC also had a significantly lower
vent rate than those with CAC (1.8% vs. 8.99%).
lthough the prognostic data available on symp-
omatic patients are not as large as those on asymp-
ts in the No CAC Versus CAC Symptomatic Patients
ratio (95% conﬁdence interval [CI]). CAC  coronary arteryven
riskomatic individuals, there is evidence that an ab-
Table 3. Studies Examining the Accuracy of Coronary Artery Calcium to Predict the Presence or Absence of Signiﬁcant Coronary Artery Stenosis by Invasive Coronary Angiogram
in Symptomatic Patients
Author/Year (Ref. #)
EBCT Reads
Blinded to
ICA Results
Total
Patients
Scanner
Type
Prevalence, n (%)
CAC 
Stenosis 
CAC 
Stenosis 
CAC 
Stenosis 
CAC 
Stenosis 
Sensitivity
(%)
Speciﬁcity
(%)
NPV
(%)
PPV
(%)CAC  0 CAC >0
Signiﬁcant
Stenosis
Breen et al./1992 (30) Yes 100 EBCT 25 (25) 75 (75) 47 (47) 47 0 28 25 100 47 100 63
Fallavollita et al./1994 (31) Yes 106 EBCT 30 (28) 76 (72) 59 (56) 50 9 26 21 85 45 70 66
Rumberger et al./1995 (32) Yes 139 EBCT 30 (22) 109 (78) 65 (47) 64 1 45 29 99 39 97 59
Budoff et al./1996 (33) N/A 710 EBCT 147 (21) 563 (79) 426 (60) 404 23 159 124 95 44 84 72
Baumgart et al./1997 (34) Yes 57 EBCT 7 (12) 50 (88) 29 (51) 28 1 22 6 97 21 86 56
Budoff et al./1998 (35) Yes 125 EBCT 45 (36) 80 (64) 73 (58) 71 1 9 44 99 83 98 89
Bielak et al./2000 (36) Yes 213 EBCT 40 (19) 173 (81) 113 (53) 111 1 62 39 99 39 98 64
Yao et al./2000 (37) Yes 64 EBCT 15 (23) 49 (77) 45 (70) 44 1 5 14 98 74 93 90
Shavelle et al./2000 (38) Yes 97 EBCT 17 (18) 80 (82) 67 (69) 64 3 16 14 96 47 82 80
Haberl et al./2001 (39) Yes 1,764 EBCT 249 (14) 1,515 (86) 935 (53) 935 5 580 244 100 30 98 62
Budoff et al./2002 (40) Yes 1,851 EBCT 385 (21) 1,466 (79) 981 (53) 945 38 521 347 96 40 90 64
Hosoi et al./2002 (41) Yes 282 EBCT 36 (13) 246 (87) 203 (72) 196 7 50 29 97 37 81 80
Budoff et al./2002 (42) Yes 1,120 EBCT 277 (25) 843 (75) 672 (60) 653 19 190 258 97 58 93 77
Knez et al./2004 (43) Yes 2,123 EBCT 334 (16) 1,789 (84) 1,253 (59) 1247 8 542 326 99 38 98 70
Haberl et al./2005 (44) Yes 133 MSCT 25 (19) 108 (81) 53 (40) 45 8 63 17 85 21 68 42
Lau et al./2005 (45) Yes 50 MSCT 6 (12) 44 (88) 30 (60) 29 1 15 5 97 25 83 66
Becker et al./2007 (46) Yes 1347 MSCT 259 (19) 1,088 (81) 714 (53) 715 5 373 254 99 41 98 66
Leschka et al./2007 (47) Yes 74 DSCT 14 (19) 60 (81) 36 (49) 36 0 24 14 100 37 100 60
Pooled data 10,355 1,941 (20) 8,414 (80) 56 5,684 131 2,730 1,810 98 40 93 68
NPV  negative predictive value; PPV  positive predictive value; other abbreviations as in Tables 1 and 2.
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683ence of CAC translates into a reduced risk for
dverse events in this population. Further studies
re needed to identify the true role of CAC in
ymptomatic individuals and how best to incorpo-
ate CAC information into the overall risk stratifi-
ation algorithm in combination with other diag-
ostic tests, such as contrast-enhanced coronary
omputed tomography (CT) angiography and/or
tress myocardial perfusion imaging.
Figure 3. Negative and Positive Predictive Value of No CAC and
Negative and positive predictive value of absence of detectable no
detected on invasive angiography, with summary statistics of 92% a
nary artery disease; CI  conﬁdence interval.
Table 4. Studies Examining the Relationship Between Coronary
Author/Year (Ref. #) Type of Population
Average
Age
(yrs)
He et al./2000 (48) 87% asymptomatic 58
Yao et al./2004 (49) Referred for SPECT on
clinical basis
52
Berman et al./2004 (50) 61% PCP, referred 8%,
self referred 31%,
research study
58
Wong et al./2005 (51) Referred for SPECT on
clinical basis
58
Blumenthal et al./2006 (52) Asymptomatic siblings
of pts with known
CAD
51
Budoff et al./2007 (53) Scheduled for ICA 54
Esteves et al./2008 (54) Referred for SPECT on
clinical basis
62
Schenker et al./2008 (29) Referred for PET on
clinical basis
61
Total 57CAD  coronary artery disease; SPECT  single-positron emission computed tomogtility of CAC in ruling out signiﬁcant CAD. Aside
rom the long-term prognostic value, our review
eveals the potential of CAC scanning to serve as
gatekeeper for further diagnostic imaging for
valuation of coronary luminal patency. There
ere 18 studies comparing the diagnostic accu-
acy of Agatston scores with ICA to detect a
ignificant (50%) stenosis of the coronary lu-
en (Table 3).
C >0
and CAC 0 for detection of signiﬁcant coronary artery disease
68%, respectively. CAC  coronary artery calcium; CAD  coro-
ery Calcium and Myocardial Ischemia
en
(%)
Total
Patients
Prevalence, n (%)
CAC
Ischem
(%CAC  0 CAC >0
Abnormal
Perfusion
79 411 37 (9) 374 (91) 81 (20) 81 (
N/A 73 29 (40) 44 (60) 41 (56) 34 (
73 1,195 250 (21) 945 (79) 76 (6) 72 (
33 1,043 282 (27) 761 (73) 77 (7) 71 (
38 260 122 (47) 138 (53) 49 (19) 35 (
70 30 6 (20) 24 (80) 19 (63) 17 (
39 84 34 (41) 50 (59) 13 (15) 13 (
41 621 213 (34) 408 (66) 179 (29) 163 (
47 3,717 973 (26) 2,744 (74) 535 (14) 486 (CA
CAC
ndArt
M

ia 
)
CAC 
Ischemia 
(%)
22) 0 (0)
77) 7 (24)
8) 4 (2)
9) 6 (2)
25) 14 (11)
71) 2 (33)
26) 0 (100)
40) 34 (16)
13) 67 (7)raphy; other abbreviations as in Tables 1 and 2.
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684The presence of CAC was highly sensitive (98%)
n predicting a luminal stenosis 50% in any
oronary artery, although the specificity was low
40%). In fact, recent American College of Cardi-
logy (ACC)/American Heart Association (AHA)
uidelines also consider that “for the symptomatic
atient, exclusion of measurable coronary calcium
ay be an effective filter before undertaking inva-
ive diagnostic procedures or hospital admission”
62,63). Although absence of CAC is associated
ith a very low likelihood of significant CAD,
pproximately 2% of symptomatic individuals with
ignificant CAD do not have evidence of CAC.
hese individuals (i.e., significant CAD without
AC) tend to be younger than 50 years of age
32,33,39,40,43,46). As a result, one must exercise
aution when evaluating patients for potential
AD in the absence of CAC.
Recent advances in contrast-enhanced coronary
T angiography have allowed for higher accuracy
n detection and exclusion of significant CAD, and
hus the role of absence of CAC in this setting
eeds further assessment. Although the pooled
ensitivity and specificity of CAC for detecting a
Figure 4. Forest Plot of the Cumulative Odds Ratio for Ischemia
The relative risk ratio is calculated using a Peto odds ratio (95% con
ining the Relationship Between Coronary Artery Calcium and Ac
#)
Total
Patients
Type of
Scanner
Mean
Age
(yrs)
Men
(%)
Prevalence
CAC  0 CAC >
) 105 EBCT 48 54 59 46
(59) 134 EBCT 53 37 48 86
4) 192 EBCT 53 54 76 116
431 51.4 48 183 2481, 2, and 3.ignificant stenosis are 98% and 40%, respectively,
he sensitivity and specificity of contrast-enhanced
4-slice CT are 97% and 90%, respectively (64).
he most practical application would be using CT
ngiography in improving on the limited specificity
f CAC for obstructive disease. Because the pres-
nce of CAC is often associated with nonobstruc-
ive disease, specificity for obstructive disease is
educed. The determination of significant stenotic
isease with CT angiography in those with the
resence of CAC will undoubtedly be useful to the
linician and patient.
However, it is important to keep in mind that
pproximately 2% of symptomatic patients with
AC may have underlying significant obstructive
picardial CAD, the significance of which is not
ntirely clear. As suggested by current ACC/AHA
uidelines, absence of CAC can serve as a possible
xclusion criterion for further cardiovascular risk
esting, as the long-term prognosis of these patients
s excellent.
revalence of myocardial ischemia in individuals with-
ut CAC. Although the absence of CAC shows
xceptional ability for predicting the absence of a
Patients With No CAC Versus CAC Patients
nce interval [CI]), random effects model.
Coronary Syndrome in an Emergency Department Population
CAC  0
With
ACS
CAC >0
With
ACS
Sensitivity
(%)
Speciﬁcity
(%)
PPV
(%)
NPV
(%)
0 14 100 63 30 100
0 7 100 54 15 100
2 56 97 55 26 97
2 77 99 57 24 99inTable 5. Studies Exam ute
Author/Year (Ref. 0
Laudon et al./1999 (58
McLaughlin et al./1999
Georgiou et al./2001 (2
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685ignificant stenosis, its ability to predict myocardial
schemia by myocardial perfusion scans (MPS) is
lso encouraging, although somewhat more modest.
he negative predictive value of CAC for a perfu-
ion abnormality was an average of 93% in 8 studies.
ore importantly, the 1 prognostic study simulta-
eously evaluating the prognostic value of both
PS and CAC scores (28) conclusively showed
hat the event risk of a person without CAC was
xtremely low regardless of whether they had isch-
mia. In fact none of the patients without CAC
ho had an abnormal MPS had an event, whereas
very low percentage of those without CAC and a
ormal MPS had an adverse outcome (0% vs. 0.2%,
espectively). The recent ACC/American Society of
uclear Cardiology appropriateness criteria state
hat a low calcium score (especially in the absence of
AC) precludes the need for MPS assessment (65).
However, in 3 studies, a significantly higher
revalence of ischemia in patients without CAC
as reported. One of these studies (52) showed that
1% of individuals without CAC had an abnormal
PS. This study was exclusively performed in
iblings of those with premature CAD. Another
tudy by Budoff et al. (53) examined a cohort of 30
ndividuals, with 70% of the subjects demonstrating
clinically significant stenosis. The investigators
ound 2 of 6 individuals (33%) without CAC to
ave ischemia on MPS. The results of this study are
emarkably discordant with other studies, not only
ecause of the study’s small sample size but also
ecause of the high prevalence of disease in this
ohort.
CS in individuals without CAC. The 3 studies eval-
ating the relationship between CAC and ACS
eported a 99% sensitivity and 99% negative pre-
ictive value, which is comparable to that of
ontrast-enhanced coronary CT angiography
66,67). On the other hand, the specificity and
ositive predictive value was modest (57% and 24%,
espectively). The total number of patients in each
f these studies was too small to conclusively
stablish the role of CAC evaluation in the emer-Coronary artery calcium area by coronary artery calceports is certainly small and inconclusive with
espect to this important clinical entity. Although
AC can serve as a useful marker for excluding
CS in patients presenting to the emergency de-
artment, further studies in larger cohorts need to
e done to establish CAC’s role in a clinical
aradigm, especially in lieu of excellent depiction of
ot only coronary anatomy but also of left ventric-
lar function with contrast-enhanced coronary CT
ngiography.
tudy limitations. This is a systematic review of a large
umber of studies consisting of heterogeneous popu-
ations. Although the results of the vast majority of
hese studies are concordant, the results might not be
eneralizable to populations that were not examined
y any of the preceding studies. It is also important to
eep in mind that no information was available in a
ajority of the studies on the effect of the absence of
AC in various pre-test CHD risk settings. However,
hen we extrapolate the data over a range of asymp-
omatic and symptomatic patients, absence of CAC
as generally demonstrated favorable prognostic value.
his key question will need to be addressed in large
opulation-based cohorts such as MESA. In addition,
or studies examining the diagnostic accuracy of CAC
o predict a significant stenosis by ICA, caregivers
ere blinded to CAC results in a majority of cases.
owever in 4 studies, the results of the ICA could
ave been driven by CAC scores (33,34,37,46).
O N C L U S I O N S
n the basis of extensive evidence in published
eports (in more than 85,000 patients), the absence
f CAC identifies a group of asymptomatic and
ymptomatic individuals at a very low cardiovascular
isk. As endorsed by current guidelines, these re-
ults should be considered strongly in current man-
gement algorithms for better utilization of health
are resources.
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